CCT241161

CCT241161 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. CCT241161 blocked growth of BRAF-mutant and NRAS-mutant melanoma cells, inhibiting MEK–ERK, in vitro and in vivo . CCT241161 also prevented growth of xenografts derived from patient tumours with acquired or intrinsic resistance to BRAF and MEK inhibitors.
Supplier Alfa Cytology
Product # BC0534
Pricing 1.0 mg, 5.0 mg, 10.0 mg, inquire
Feedback